Company to Settle Accrued Interest with Common Shares

Business 뉴스

Company to Settle Accrued Interest with Common Shares
FINANCEINTEREST SETTLEMENTCONVERTIBLE DEBENTURES

The company announced its plan to settle accrued interest on various convertible debentures by issuing common shares to holders. The settlement date and share price are subject to certain conditions and regulations. The news release also includes forward-looking statements about future plans and objectives.

  • 📰 mining
  • ⏱ Reading Time:
  • 19 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 53%

,764 in accrued interest due under the Company's previously issued Replacement Series A Convertible Debentures, Replacement Series B Convertible Debenture, Series C Convertible Debentures, Series D Convertible Debentures and Series E Convertible Debentures onUnless permitted under securities legislation, the common shares issued to settle accrued interest under the Company's Series E Convertible Debentures are subject to a hold period expiring onThis news release includes...

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.Why artisanal miners need a digital investment marketplaceMarimaca reported results from the maiden scout drilling program at the Pias target, located northwest of Pampa Medina within the broader Sierra de Medina property block.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

mining /  🏆 449. in KR
 

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

McKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.
더 많은 것을 읽으십시오 »

McKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.
더 많은 것을 읽으십시오 »

McKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.
더 많은 것을 읽으십시오 »

McKinsey & Company to pay $650 million to settle opioid consulting probe, ex-partner to plead guiltyMcKinsey & Company to pay $650 million to settle opioid consulting probe, ex-partner to plead guiltyThe Department of Justice had investigated McKinsey & Company for its consulting work with Purdue Pharma, the prescription opioid maker.
더 많은 것을 읽으십시오 »

McKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.
더 많은 것을 읽으십시오 »

McKinsey and Company agrees to pay $650 million to settle federal probe over opioids workMcKinsey and Company agrees to pay $650 million to settle federal probe over opioids workCourt papers were filed in Virginia.
더 많은 것을 읽으십시오 »



Render Time: 2025-01-19 23:25:35